| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |